Clear Search

Books+ Search Results

Subject: "Industries United States"
Subject (Genre): Is
Is Is Not
Legislative hearings
Subject: Is
Is Is Not
Drugs

Advanced Search

Basic Search
Help
Add a row
Reset

Limit results by

Show Online Results Only
Online Results (13)
1.
Reforming the drug compounding regulatory framework : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, July 16, 2013
Author
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health, author
Published
Washington : U.S. Government Printing Office, 2014.
Washington, District of Columbia : For sale by the Superintendent of Documents, U.S. Government Printing Office
Location
Library Shelving Facility (LSF) >> Y 4.C 73/8:113-70
Format
Books
2.
The role of pharmacy benefit managers in prescription drug markets : hearing before the Committee on Oversight and Accountability, House of Representatives, One Hundred Eighteenth Congress, first session
Author
United States. Congress. House. Committee on Oversight and Accountability, author
Published
Washington : U.S. Government Publishing Office, 2023.
Location
Library Shelving Facility (LSF) >> Y 4.OV 2:118-36
Format
Books
3.
Making health care more affordable : lowering drug prices and increasing transparency : hearing before the Subcommittee on Health, Employment, Labor and Pensions, Committee on Education and Labor, U.S. House of Representatives, One Hundred Sixteenth Congress, first session : hearing held in Washington, DC, September 26, 2019
Author
United States. Congress. House. Committee on Education and Labor. Subcommittee on Health, Employment, Labor, and Pensions, author
Published
Washington : U.S. Government Publishing Office, 2021.
Online
https://purl.fdlp.gov/GPO/gpo150498
Location
Yale Internet Resource >> None
Format
Books / Online
4.
Drug pricing in America : a prescription for change : hearing before the Committee on Finance, United States Senate, One Hundred Sixteenth Congress, first session, February 28, 2019
Author
United States. Congress. Senate. Committee on Finance, author
Published
Washington : U.S. Government Publishing Office, 2019.
Online
https://purl.fdlp.gov/GPO/gpo124181
Location
Yale Internet Resource >> None
Format
Books / Online
5.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Online
http://purl.fdlp.gov/GPO/gpo77020
Location
Yale Internet Resource >> None
Format
Books / Online
6.
Treating the opioid epidemic : the state of competition in the markets for addiction medication : hearing before the Subcommittee on Regulatory Reform, Commercial and Antitrust Law of the Committee on the Judiciary, House of Representatives, One Hundred Fourteenth Congress, second session, September 22, 2016
Author
United States. Congress. House. Committee on the Judiciary. Subcommittee on Regulatory Reform, Commercial and Antitrust Law, author
Published
Washington : U.S. Government Publishing Office, 2017.
Washington, DC : For sale by the Superintendent of Documents, U.S. Government Publishing Office
Location
Library Shelving Facility (LSF) >> Y 4.J 89/1:114-97
Format
Books
7.
Unsustainable drug prices : testimony from the CEOs : hearing before the Committee on Oversight and Reform, House of Representatives, One Hundred Sixteenth Congress, second session
Author
United States. Congress. House. Committee on Oversight and Reform, author
Published
Washington : U.S. Government Publishing Office, 2020.
Online
https://purl.fdlp.gov/GPO/gpo149312
Location
Yale Internet Resource >> None
Format
Books / Online
8.
Legislative proposal to increase funding for medical research : hearing before a subcommittee of the Committee on Appropriations, United States Senate, One Hundred Fifth Congress, first session, special hearing
Author
United States. Congress. Senate. Committee on Appropriations. Subcommittee on Departments of Labor, Health and Human Services, Education, and Related Agencies, author
Published
Washington : U.S. Government Printing Office, 1998.
Online
https://purl.fdlp.gov/GPO/gpo93960
Location
Yale Internet Resource >> None
Format
Books / Online
9.
The complex web of prescription drug prices : examining agency efforts to further competition and increase affordability : hearing before the Special Committee on Aging, United States Senate, One Hundred Sixteenth Congress, first session, Washington, DC, June 19, 2019
Author
United States. Congress. Senate. Special Committee on Aging, author
Published
Washington : U.S. Government Publishing Office, 2022.
Online
https://purl.fdlp.gov/GPO/gpo183063
Location
Yale Internet Resource >> None
Format
Books / Online
10.
EpiPen price increases : how regulatory barriers inhibit pharmaceutical competition : field hearing of the Subcommittee on Children and Families of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Fourteenth Congress, second session on examining EpiPen price increases, focusing on how regulatory barriers inhibit pharmaceutical competition, October 7, 2016 (Lexington, KY)
Author
United States. Congress. Senate. Committee on Health, Education, Labor, and Pensions. Subcommittee on Children and Families, author
Published
Washington : U.S. Government Publishing Office, 2018.
Online
https://purl.fdlp.gov/GPO/gpo113215
Location
Yale Internet Resource >> None
Format
Books / Online